Vered Bisker-Leib
Chief Executive Officer presso COMPASS THERAPEUTICS, INC.
Patrimonio netto: 6 M $ in data 31/03/2024
Profilo
Vered Bisker-Leib is the founder of Imara, Inc. She currently holds multiple positions including CEO, CFO, Chief Financial Officer & Director at Compass Therapeutics, Inc., Independent Director at Ayala Pharmaceuticals, Inc., and Manager at Compass Therapeutics LLC.
Previously, she served as a Director at Advaxis, Inc., Independent Director at Old Ayala, Inc., Member-Strategic Transactions Group at Bristol Myers Squibb Co., Chief Business Officer at Cydan II, Inc., and Chief Operating Officer at Olivia Ventures, Inc. Dr. Bisker-Leib obtained an MBA and a doctorate from the University of Massachusetts, and an undergraduate degree from Technion-Israel Institute of Technology.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 08/02/2024 | 3 124 426 ( 2.27% ) | 6 M $ | 31/03/2024 |
Posizioni attive di Vered Bisker-Leib
| Società | Posizione | Inizio |
|---|---|---|
| COMPASS THERAPEUTICS, INC. | Chief Executive Officer | 09/01/2024 |
| AYALA PHARMACEUTICALS, INC. | Director/Board Member | 01/08/2020 |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Precedenti posizioni note di Vered Bisker-Leib
| Società | Posizione | Fine |
|---|---|---|
| ADVAXIS, INC. | Director/Board Member | 19/01/2023 |
Cydan II, Inc.
 Cydan II, Inc. Pharmaceuticals: GenericHealth Technology Cydan II, Inc. develops and commercializes drugs for orphan and diseases. The firm evaluates products for treating rare diseases with high unmet medical need to start multiple companies to develop such therapies. The company was founded by Cristina Csimma, James G. McArthur, Deborah S. Geraghty and Christoph M. Adams in 2013 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/11/2016 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2013 |
| AYALA PHARMACEUTICALS, INC. | Director/Board Member | - |
| IMARA | Founder | - |
Formazione di Vered Bisker-Leib
| University of Massachusetts | Doctorate Degree |
| Technion-Israel Institute of Technology | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| COMPASS THERAPEUTICS, INC. | Health Technology |
| AYALA PHARMACEUTICALS, INC. | Commercial Services |
| Aziende private | 6 |
|---|---|
Compass Therapeutics LLC
Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Health Technology |
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
Cydan II, Inc.
Cydan II, Inc. Pharmaceuticals: GenericHealth Technology Cydan II, Inc. develops and commercializes drugs for orphan and diseases. The firm evaluates products for treating rare diseases with high unmet medical need to start multiple companies to develop such therapies. The company was founded by Cristina Csimma, James G. McArthur, Deborah S. Geraghty and Christoph M. Adams in 2013 and is headquartered in Cambridge, MA. | Health Technology |
Imara, Inc.
 Imara, Inc. Pharmaceuticals: MajorHealth Technology Imara, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel therapeutics to treat patients suffering from hemoglobinopathies. The company was founded by James Gregg McArthur in 2016 and is headquartered in Brookline, MA. | Health Technology |
Olivia Ventures, Inc.
 Olivia Ventures, Inc. Financial ConglomeratesFinance Olivia Ventures, Inc. is a blank check company. It acts as a vehicle to investigate and to pursue a business combination. The company was founded on March 20, 2018 and is headquartered in Boca Raton, FL. | Finance |
Old Ayala, Inc.
 Old Ayala, Inc. Pharmaceuticals: MajorHealth Technology Old Ayala, Inc. operates as a clinical-stage oncology company. It focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. It also involved in in precision oncology, targeted therapy, drug development, companion diagnostics, and biomarkers. The company was founded in November 2017 and is headquartered in Rehovot, Israel. | Health Technology |
- Borsa valori
- Insiders
- Vered Bisker-Leib
